Launay, Manon PharmD, PhD*; Correia, Patricia MD†; Thiery, Guillaume MD, PhD‡; Ragey, Sophie Perinel MD, PhD§
* Service de Médecine Intensive Réanimation et Pôle de Biologie-Pathologie, CHU Saint-Étienne, France;
† Université Jean Monnet Saint-Étienne, CHU Saint-Étienne, Service de Médecine Intensive Réanimation, France;
‡ Service de Médecine Intensive Réanimation, CHU de Saint-Etienne. Université Jean Monnet, Saint-Etienne. Research on Healthcare Performance Reshape, France; and
§Université Jean Monnet Saint-Étienne, CHU Saint-Étienne, Service de Médecine Intensive Réanimation, Mines Saint-Etienne, Inserm, Sainbiose, France.
There was no specific funding for this study.
The authors have no conflict of interest to declare.
Study conception and design: all authors. Statistical analysis: M. Launay. Data curation: M. Launay, P. Correia, and S. P. Ragey. Manuscript drafting: all authors. Critical revision: all authors.
Therapeutic Drug Monitoring ():10.1097/FTD.0000000000001109, May 23, 2023. | DOI: 10.1097/FTD.0000000000001109